Logo for GRAIL

GRAIL Investor Relations Material

Latest events

Logo for GRAIL

Q4 2024

GRAIL
Logo for GRAIL

Q4 2024

20 Feb, 2025
Logo for GRAIL

Q3 2024

12 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from GRAIL

Access all reports
GRAIL, Inc. is a biotechnology company specializing in the development of advanced technologies for early cancer detection. The company's primary product is the Galleri test, a multi-cancer early detection test designed to screen for a wide range of cancers, particularly those without current recommended screenings. In addition to Galleri, GRAIL is also working on diagnostic aids and minimal residual disease tests to assist in the detection and monitoring of cancer. The company is headquartered in Menlo Park, California, and its shares are listed on the Nasdaq.